Global Chicken Newcastle Disease Vaccine Market Growth 2026-2032
The global Chicken Newcastle Disease Vaccine market size is predicted to grow from US$ 271 million in 2025 to US$ 341 million in 2032; it is expected to grow at a CAGR of 3.4% from 2026 to 2032.
Chicken Newcastle Disease Vaccine is a core veterinary biological product designed to prevent Newcastle disease virus (NDV) infection in poultry, particularly chickens, including broilers, layers, and breeders. The vaccine stimulates both humoral and cellular immune responses to establish long-term protection, effectively reducing morbidity, mortality, and transmission risks. Based on technological approaches, it mainly includes live attenuated vaccines, inactivated vaccines, and recombinant vaccines, each tailored to different farming systems and immunization strategies. With the increasing scale and industrialization of poultry farming, this vaccine has evolved from a basic preventive measure into a critical risk management tool, playing a vital role in ensuring food safety, stabilizing supply chains, and improving production efficiency.In 2025, global Chicken Newcastle Disease Vaccine production reached approximately 110.63 billion doses and price is about 2.5 USD/ K Dose. The average gross profit margin of this product is 15%.
Driven by the continuous growth in global poultry consumption and the increasing industrialization of poultry farming, demand for chicken Newcastle disease vaccines remains strong and resilient. Governments worldwide are strengthening animal disease control systems, incorporating key vaccines into mandatory or recommended immunization programs, providing institutional support for the industry. According to corporate disclosures and industry practices, large-scale poultry producers are increasing investment in biosecurity, transforming vaccines from a cost factor into a production assurance tool. Meanwhile, vaccine technologies are advancing toward higher efficacy, improved safety, and multivalent formulations, driving product upgrades and enhancing industry value.Despite favorable growth prospects, the industry faces multiple challenges. Vaccine production requires stringent biosafety standards, strict quality control, and long development cycles, increasing operational complexity. Regional variations in viral strains demand continuous technological upgrades to maintain effectiveness. Intense price competition and product homogenization in certain markets put pressure on profitability. In addition, limitations in cold chain infrastructure and inconsistent vaccination practices at the grassroots level may affect real-world efficacy.Downstream demand is undergoing a structural shift from fragmented farming to large-scale, standardized, and integrated production systems. Large poultry enterprises are establishing systematic immunization programs, demanding higher consistency, stability, and long-term protection from vaccines. At the same time, rapid expansion of poultry farming in emerging markets is driving demand growth across Asia, Africa, and Latin America. Increasing awareness of food safety and animal welfare is also boosting demand for vaccines with improved safety profiles and reduced side effects, accelerating industry premiumization.From a supply chain perspective, upstream components include viral seed strains, SPF embryonated eggs, cell culture systems, and adjuvants. High-quality seed strains and stable cultivation systems form the foundation of vaccine development and production, directly impacting efficacy and safety. With ongoing advancements in biotechnology, upstream processes are becoming more standardized, scalable, and controllable, although key resources still present high technical barriers. Supply chain stability and quality consistency are increasingly critical for long-term competitiveness in the industry.
LP Information, Inc. (LPI) ' newest research report, the ?Chicken Newcastle Disease Vaccine Industry Forecast? looks at past sales and reviews total world Chicken Newcastle Disease Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Chicken Newcastle Disease Vaccine sales for 2026 through 2032. With Chicken Newcastle Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chicken Newcastle Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Chicken Newcastle Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chicken Newcastle Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Chicken Newcastle Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chicken Newcastle Disease Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chicken Newcastle Disease Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Chicken Newcastle Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Chicken Newcastle Disease Vaccine is a core veterinary biological product designed to prevent Newcastle disease virus (NDV) infection in poultry, particularly chickens, including broilers, layers, and breeders. The vaccine stimulates both humoral and cellular immune responses to establish long-term protection, effectively reducing morbidity, mortality, and transmission risks. Based on technological approaches, it mainly includes live attenuated vaccines, inactivated vaccines, and recombinant vaccines, each tailored to different farming systems and immunization strategies. With the increasing scale and industrialization of poultry farming, this vaccine has evolved from a basic preventive measure into a critical risk management tool, playing a vital role in ensuring food safety, stabilizing supply chains, and improving production efficiency.In 2025, global Chicken Newcastle Disease Vaccine production reached approximately 110.63 billion doses and price is about 2.5 USD/ K Dose. The average gross profit margin of this product is 15%.
Driven by the continuous growth in global poultry consumption and the increasing industrialization of poultry farming, demand for chicken Newcastle disease vaccines remains strong and resilient. Governments worldwide are strengthening animal disease control systems, incorporating key vaccines into mandatory or recommended immunization programs, providing institutional support for the industry. According to corporate disclosures and industry practices, large-scale poultry producers are increasing investment in biosecurity, transforming vaccines from a cost factor into a production assurance tool. Meanwhile, vaccine technologies are advancing toward higher efficacy, improved safety, and multivalent formulations, driving product upgrades and enhancing industry value.Despite favorable growth prospects, the industry faces multiple challenges. Vaccine production requires stringent biosafety standards, strict quality control, and long development cycles, increasing operational complexity. Regional variations in viral strains demand continuous technological upgrades to maintain effectiveness. Intense price competition and product homogenization in certain markets put pressure on profitability. In addition, limitations in cold chain infrastructure and inconsistent vaccination practices at the grassroots level may affect real-world efficacy.Downstream demand is undergoing a structural shift from fragmented farming to large-scale, standardized, and integrated production systems. Large poultry enterprises are establishing systematic immunization programs, demanding higher consistency, stability, and long-term protection from vaccines. At the same time, rapid expansion of poultry farming in emerging markets is driving demand growth across Asia, Africa, and Latin America. Increasing awareness of food safety and animal welfare is also boosting demand for vaccines with improved safety profiles and reduced side effects, accelerating industry premiumization.From a supply chain perspective, upstream components include viral seed strains, SPF embryonated eggs, cell culture systems, and adjuvants. High-quality seed strains and stable cultivation systems form the foundation of vaccine development and production, directly impacting efficacy and safety. With ongoing advancements in biotechnology, upstream processes are becoming more standardized, scalable, and controllable, although key resources still present high technical barriers. Supply chain stability and quality consistency are increasingly critical for long-term competitiveness in the industry.
LP Information, Inc. (LPI) ' newest research report, the ?Chicken Newcastle Disease Vaccine Industry Forecast? looks at past sales and reviews total world Chicken Newcastle Disease Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Chicken Newcastle Disease Vaccine sales for 2026 through 2032. With Chicken Newcastle Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chicken Newcastle Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Chicken Newcastle Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chicken Newcastle Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Chicken Newcastle Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chicken Newcastle Disease Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chicken Newcastle Disease Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Chicken Newcastle Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Live Vaccine
- Inactivated Vaccine
- Spray Method
- Drinking Water
- Injection Method
- Large Farms
- Small Farms
- Government Use
- Chicken
- Adult Chicken
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- CEVA
- CAHIC
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- Elanco
- FATRO
- CAVAC
- Vaksindo
- Virbac
- Hester Biosciences
- What is the 10-year outlook for the global Chicken Newcastle Disease Vaccine market?
- What factors are driving Chicken Newcastle Disease Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doChicken Newcastle Disease Vaccine market opportunities vary by end market size?
- How does Chicken Newcastle Disease Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chicken Newcastle Disease Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Chicken Newcastle Disease Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Chicken Newcastle Disease Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Chicken Newcastle Disease Vaccine Segment by Type
2.2.1 Live Vaccine
2.2.2 Inactivated Vaccine
2.2.3 Chicken Newcastle Disease Vaccine Sales by Type
2.2.3.1 Global Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Chicken Newcastle Disease Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Chicken Newcastle Disease Vaccine Sale Price by Type (2021-2026)
2.3 Chicken Newcastle Disease Vaccine Segment by Administration
2.3.1 Spray Method
2.3.2 Drinking Water
2.3.3 Injection Method
2.3.4 Chicken Newcastle Disease Vaccine Sales by Administration
2.3.4.1 Global Chicken Newcastle Disease Vaccine Sales Market Share by Administration (2021-2026)
2.3.4.2 Global Chicken Newcastle Disease Vaccine Revenue and Market Share by Administration (2021-2026)
2.3.4.3 Global Chicken Newcastle Disease Vaccine Sale Price by Administration (2021-2026)
2.4 Chicken Newcastle Disease Vaccine Segment by End User
2.4.1 Large Farms
2.4.2 Small Farms
2.4.3 Government Use
2.4.4 Chicken Newcastle Disease Vaccine Sales by End User
2.4.4.1 Global Chicken Newcastle Disease Vaccine Sales Market Share by End User (2021-2026)
2.4.4.2 Global Chicken Newcastle Disease Vaccine Revenue and Market Share by End User (2021-2026)
2.4.4.3 Global Chicken Newcastle Disease Vaccine Sale Price by End User (2021-2026)
2.5 Chicken Newcastle Disease Vaccine Segment by Application
2.5.1 Chicken
2.5.2 Adult Chicken
2.5.3 Chicken Newcastle Disease Vaccine Sales by Application
2.5.3.1 Global Chicken Newcastle Disease Vaccine Sale Market Share by Application (2021-2026)
2.5.3.2 Global Chicken Newcastle Disease Vaccine Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Chicken Newcastle Disease Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Chicken Newcastle Disease Vaccine Breakdown Data by Company
3.1.1 Global Chicken Newcastle Disease Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Chicken Newcastle Disease Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Chicken Newcastle Disease Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Chicken Newcastle Disease Vaccine Revenue by Company (2021-2026)
3.2.2 Global Chicken Newcastle Disease Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Chicken Newcastle Disease Vaccine Sale Price by Company
3.4 Key Manufacturers Chicken Newcastle Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chicken Newcastle Disease Vaccine Product Location Distribution
3.4.2 Players Chicken Newcastle Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CHICKEN NEWCASTLE DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Chicken Newcastle Disease Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Chicken Newcastle Disease Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Chicken Newcastle Disease Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Chicken Newcastle Disease Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Chicken Newcastle Disease Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Chicken Newcastle Disease Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Chicken Newcastle Disease Vaccine Sales Growth
4.4 APAC Chicken Newcastle Disease Vaccine Sales Growth
4.5 Europe Chicken Newcastle Disease Vaccine Sales Growth
4.6 Middle East & Africa Chicken Newcastle Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas Chicken Newcastle Disease Vaccine Sales by Country
5.1.1 Americas Chicken Newcastle Disease Vaccine Sales by Country (2021-2026)
5.1.2 Americas Chicken Newcastle Disease Vaccine Revenue by Country (2021-2026)
5.2 Americas Chicken Newcastle Disease Vaccine Sales by Type (2021-2026)
5.3 Americas Chicken Newcastle Disease Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chicken Newcastle Disease Vaccine Sales by Region
6.1.1 APAC Chicken Newcastle Disease Vaccine Sales by Region (2021-2026)
6.1.2 APAC Chicken Newcastle Disease Vaccine Revenue by Region (2021-2026)
6.2 APAC Chicken Newcastle Disease Vaccine Sales by Type (2021-2026)
6.3 APAC Chicken Newcastle Disease Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chicken Newcastle Disease Vaccine by Country
7.1.1 Europe Chicken Newcastle Disease Vaccine Sales by Country (2021-2026)
7.1.2 Europe Chicken Newcastle Disease Vaccine Revenue by Country (2021-2026)
7.2 Europe Chicken Newcastle Disease Vaccine Sales by Type (2021-2026)
7.3 Europe Chicken Newcastle Disease Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chicken Newcastle Disease Vaccine by Country
8.1.1 Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Chicken Newcastle Disease Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chicken Newcastle Disease Vaccine
10.3 Manufacturing Process Analysis of Chicken Newcastle Disease Vaccine
10.4 Industry Chain Structure of Chicken Newcastle Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chicken Newcastle Disease Vaccine Distributors
11.3 Chicken Newcastle Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR CHICKEN NEWCASTLE DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global Chicken Newcastle Disease Vaccine Market Size Forecast by Region
12.1.1 Global Chicken Newcastle Disease Vaccine Forecast by Region (2027-2032)
12.1.2 Global Chicken Newcastle Disease Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Chicken Newcastle Disease Vaccine Forecast by Type (2027-2032)
12.7 Global Chicken Newcastle Disease Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 CEVA
13.2.1 CEVA Company Information
13.2.2 CEVA Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.2.3 CEVA Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CEVA Main Business Overview
13.2.5 CEVA Latest Developments
13.3 CAHIC
13.3.1 CAHIC Company Information
13.3.2 CAHIC Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.3.3 CAHIC Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CAHIC Main Business Overview
13.3.5 CAHIC Latest Developments
13.4 Ringpu Biology
13.4.1 Ringpu Biology Company Information
13.4.2 Ringpu Biology Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.4.3 Ringpu Biology Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Ringpu Biology Main Business Overview
13.4.5 Ringpu Biology Latest Developments
13.5 Yebio
13.5.1 Yebio Company Information
13.5.2 Yebio Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.5.3 Yebio Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yebio Main Business Overview
13.5.5 Yebio Latest Developments
13.6 Harbin Veterinary Research Institute
13.6.1 Harbin Veterinary Research Institute Company Information
13.6.2 Harbin Veterinary Research Institute Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.6.3 Harbin Veterinary Research Institute Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Harbin Veterinary Research Institute Main Business Overview
13.6.5 Harbin Veterinary Research Institute Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.7.3 Merck Animal Health Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 DHN
13.8.1 DHN Company Information
13.8.2 DHN Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.8.3 DHN Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 DHN Main Business Overview
13.8.5 DHN Latest Developments
13.9 Zoetis
13.9.1 Zoetis Company Information
13.9.2 Zoetis Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.9.3 Zoetis Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Zoetis Main Business Overview
13.9.5 Zoetis Latest Developments
13.10 Elanco
13.10.1 Elanco Company Information
13.10.2 Elanco Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.10.3 Elanco Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Elanco Main Business Overview
13.10.5 Elanco Latest Developments
13.11 FATRO
13.11.1 FATRO Company Information
13.11.2 FATRO Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.11.3 FATRO Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 FATRO Main Business Overview
13.11.5 FATRO Latest Developments
13.12 CAVAC
13.12.1 CAVAC Company Information
13.12.2 CAVAC Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.12.3 CAVAC Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 CAVAC Main Business Overview
13.12.5 CAVAC Latest Developments
13.13 Vaksindo
13.13.1 Vaksindo Company Information
13.13.2 Vaksindo Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.13.3 Vaksindo Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Vaksindo Main Business Overview
13.13.5 Vaksindo Latest Developments
13.14 Virbac
13.14.1 Virbac Company Information
13.14.2 Virbac Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.14.3 Virbac Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Virbac Main Business Overview
13.14.5 Virbac Latest Developments
13.15 Hester Biosciences
13.15.1 Hester Biosciences Company Information
13.15.2 Hester Biosciences Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.15.3 Hester Biosciences Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Hester Biosciences Main Business Overview
13.15.5 Hester Biosciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chicken Newcastle Disease Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Chicken Newcastle Disease Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Chicken Newcastle Disease Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Chicken Newcastle Disease Vaccine Segment by Type
2.2.1 Live Vaccine
2.2.2 Inactivated Vaccine
2.2.3 Chicken Newcastle Disease Vaccine Sales by Type
2.2.3.1 Global Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Chicken Newcastle Disease Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Chicken Newcastle Disease Vaccine Sale Price by Type (2021-2026)
2.3 Chicken Newcastle Disease Vaccine Segment by Administration
2.3.1 Spray Method
2.3.2 Drinking Water
2.3.3 Injection Method
2.3.4 Chicken Newcastle Disease Vaccine Sales by Administration
2.3.4.1 Global Chicken Newcastle Disease Vaccine Sales Market Share by Administration (2021-2026)
2.3.4.2 Global Chicken Newcastle Disease Vaccine Revenue and Market Share by Administration (2021-2026)
2.3.4.3 Global Chicken Newcastle Disease Vaccine Sale Price by Administration (2021-2026)
2.4 Chicken Newcastle Disease Vaccine Segment by End User
2.4.1 Large Farms
2.4.2 Small Farms
2.4.3 Government Use
2.4.4 Chicken Newcastle Disease Vaccine Sales by End User
2.4.4.1 Global Chicken Newcastle Disease Vaccine Sales Market Share by End User (2021-2026)
2.4.4.2 Global Chicken Newcastle Disease Vaccine Revenue and Market Share by End User (2021-2026)
2.4.4.3 Global Chicken Newcastle Disease Vaccine Sale Price by End User (2021-2026)
2.5 Chicken Newcastle Disease Vaccine Segment by Application
2.5.1 Chicken
2.5.2 Adult Chicken
2.5.3 Chicken Newcastle Disease Vaccine Sales by Application
2.5.3.1 Global Chicken Newcastle Disease Vaccine Sale Market Share by Application (2021-2026)
2.5.3.2 Global Chicken Newcastle Disease Vaccine Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Chicken Newcastle Disease Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Chicken Newcastle Disease Vaccine Breakdown Data by Company
3.1.1 Global Chicken Newcastle Disease Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Chicken Newcastle Disease Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Chicken Newcastle Disease Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Chicken Newcastle Disease Vaccine Revenue by Company (2021-2026)
3.2.2 Global Chicken Newcastle Disease Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Chicken Newcastle Disease Vaccine Sale Price by Company
3.4 Key Manufacturers Chicken Newcastle Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chicken Newcastle Disease Vaccine Product Location Distribution
3.4.2 Players Chicken Newcastle Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CHICKEN NEWCASTLE DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Chicken Newcastle Disease Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Chicken Newcastle Disease Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Chicken Newcastle Disease Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Chicken Newcastle Disease Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Chicken Newcastle Disease Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Chicken Newcastle Disease Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Chicken Newcastle Disease Vaccine Sales Growth
4.4 APAC Chicken Newcastle Disease Vaccine Sales Growth
4.5 Europe Chicken Newcastle Disease Vaccine Sales Growth
4.6 Middle East & Africa Chicken Newcastle Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas Chicken Newcastle Disease Vaccine Sales by Country
5.1.1 Americas Chicken Newcastle Disease Vaccine Sales by Country (2021-2026)
5.1.2 Americas Chicken Newcastle Disease Vaccine Revenue by Country (2021-2026)
5.2 Americas Chicken Newcastle Disease Vaccine Sales by Type (2021-2026)
5.3 Americas Chicken Newcastle Disease Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chicken Newcastle Disease Vaccine Sales by Region
6.1.1 APAC Chicken Newcastle Disease Vaccine Sales by Region (2021-2026)
6.1.2 APAC Chicken Newcastle Disease Vaccine Revenue by Region (2021-2026)
6.2 APAC Chicken Newcastle Disease Vaccine Sales by Type (2021-2026)
6.3 APAC Chicken Newcastle Disease Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chicken Newcastle Disease Vaccine by Country
7.1.1 Europe Chicken Newcastle Disease Vaccine Sales by Country (2021-2026)
7.1.2 Europe Chicken Newcastle Disease Vaccine Revenue by Country (2021-2026)
7.2 Europe Chicken Newcastle Disease Vaccine Sales by Type (2021-2026)
7.3 Europe Chicken Newcastle Disease Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chicken Newcastle Disease Vaccine by Country
8.1.1 Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Chicken Newcastle Disease Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chicken Newcastle Disease Vaccine
10.3 Manufacturing Process Analysis of Chicken Newcastle Disease Vaccine
10.4 Industry Chain Structure of Chicken Newcastle Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chicken Newcastle Disease Vaccine Distributors
11.3 Chicken Newcastle Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR CHICKEN NEWCASTLE DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global Chicken Newcastle Disease Vaccine Market Size Forecast by Region
12.1.1 Global Chicken Newcastle Disease Vaccine Forecast by Region (2027-2032)
12.1.2 Global Chicken Newcastle Disease Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Chicken Newcastle Disease Vaccine Forecast by Type (2027-2032)
12.7 Global Chicken Newcastle Disease Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 CEVA
13.2.1 CEVA Company Information
13.2.2 CEVA Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.2.3 CEVA Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CEVA Main Business Overview
13.2.5 CEVA Latest Developments
13.3 CAHIC
13.3.1 CAHIC Company Information
13.3.2 CAHIC Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.3.3 CAHIC Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CAHIC Main Business Overview
13.3.5 CAHIC Latest Developments
13.4 Ringpu Biology
13.4.1 Ringpu Biology Company Information
13.4.2 Ringpu Biology Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.4.3 Ringpu Biology Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Ringpu Biology Main Business Overview
13.4.5 Ringpu Biology Latest Developments
13.5 Yebio
13.5.1 Yebio Company Information
13.5.2 Yebio Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.5.3 Yebio Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yebio Main Business Overview
13.5.5 Yebio Latest Developments
13.6 Harbin Veterinary Research Institute
13.6.1 Harbin Veterinary Research Institute Company Information
13.6.2 Harbin Veterinary Research Institute Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.6.3 Harbin Veterinary Research Institute Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Harbin Veterinary Research Institute Main Business Overview
13.6.5 Harbin Veterinary Research Institute Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.7.3 Merck Animal Health Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 DHN
13.8.1 DHN Company Information
13.8.2 DHN Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.8.3 DHN Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 DHN Main Business Overview
13.8.5 DHN Latest Developments
13.9 Zoetis
13.9.1 Zoetis Company Information
13.9.2 Zoetis Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.9.3 Zoetis Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Zoetis Main Business Overview
13.9.5 Zoetis Latest Developments
13.10 Elanco
13.10.1 Elanco Company Information
13.10.2 Elanco Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.10.3 Elanco Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Elanco Main Business Overview
13.10.5 Elanco Latest Developments
13.11 FATRO
13.11.1 FATRO Company Information
13.11.2 FATRO Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.11.3 FATRO Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 FATRO Main Business Overview
13.11.5 FATRO Latest Developments
13.12 CAVAC
13.12.1 CAVAC Company Information
13.12.2 CAVAC Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.12.3 CAVAC Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 CAVAC Main Business Overview
13.12.5 CAVAC Latest Developments
13.13 Vaksindo
13.13.1 Vaksindo Company Information
13.13.2 Vaksindo Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.13.3 Vaksindo Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Vaksindo Main Business Overview
13.13.5 Vaksindo Latest Developments
13.14 Virbac
13.14.1 Virbac Company Information
13.14.2 Virbac Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.14.3 Virbac Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Virbac Main Business Overview
13.14.5 Virbac Latest Developments
13.15 Hester Biosciences
13.15.1 Hester Biosciences Company Information
13.15.2 Hester Biosciences Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
13.15.3 Hester Biosciences Chicken Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Hester Biosciences Main Business Overview
13.15.5 Hester Biosciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Chicken Newcastle Disease Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Chicken Newcastle Disease Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Live Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Global Chicken Newcastle Disease Vaccine Sales by Type (2021-2026) & (K Doses)
Table 6. Global Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Chicken Newcastle Disease Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Chicken Newcastle Disease Vaccine Sale Price by Type (2021-2026) & (US$/K Doses)
Table 10. Major Players of Spray Method
Table 11. Major Players of Drinking Water
Table 12. Major Players of Injection Method
Table 13. Global Chicken Newcastle Disease Vaccine Sales by Administration (2021-2026) & (K Doses)
Table 14. Global Chicken Newcastle Disease Vaccine Sales Market Share by Administration (2021-2026)
Table 15. Global Chicken Newcastle Disease Vaccine Revenue by Administration (2021-2026) & ($ million)
Table 16. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Administration (2021-2026)
Table 17. Global Chicken Newcastle Disease Vaccine Sale Price by Administration (2021-2026) & (US$/K Doses)
Table 18. Major Players of Large Farms
Table 19. Major Players of Small Farms
Table 20. Major Players of Government Use
Table 21. Global Chicken Newcastle Disease Vaccine Sales by End User (2021-2026) & (K Doses)
Table 22. Global Chicken Newcastle Disease Vaccine Sales Market Share by End User (2021-2026)
Table 23. Global Chicken Newcastle Disease Vaccine Revenue by End User (2021-2026) & ($ million)
Table 24. Global Chicken Newcastle Disease Vaccine Revenue Market Share by End User (2021-2026)
Table 25. Global Chicken Newcastle Disease Vaccine Sale Price by End User (2021-2026) & (US$/K Doses)
Table 26. Global Chicken Newcastle Disease Vaccine Sale by Application (2021-2026) & (K Doses)
Table 27. Global Chicken Newcastle Disease Vaccine Sale Market Share by Application (2021-2026)
Table 28. Global Chicken Newcastle Disease Vaccine Revenue by Application (2021-2026) & ($ million)
Table 29. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Application (2021-2026)
Table 30. Global Chicken Newcastle Disease Vaccine Sale Price by Application (2021-2026) & (US$/K Doses)
Table 31. Global Chicken Newcastle Disease Vaccine Sales by Company (2021-2026) & (K Doses)
Table 32. Global Chicken Newcastle Disease Vaccine Sales Market Share by Company (2021-2026)
Table 33. Global Chicken Newcastle Disease Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Company (2021-2026)
Table 35. Global Chicken Newcastle Disease Vaccine Sale Price by Company (2021-2026) & (US$/K Doses)
Table 36. Key Manufacturers Chicken Newcastle Disease Vaccine Producing Area Distribution and Sales Area
Table 37. Players Chicken Newcastle Disease Vaccine Products Offered
Table 38. Chicken Newcastle Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Chicken Newcastle Disease Vaccine Sales by Geographic Region (2021-2026) & (K Doses)
Table 42. Global Chicken Newcastle Disease Vaccine Sales Market Share Geographic Region (2021-2026)
Table 43. Global Chicken Newcastle Disease Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Chicken Newcastle Disease Vaccine Sales by Country/Region (2021-2026) & (K Doses)
Table 46. Global Chicken Newcastle Disease Vaccine Sales Market Share by Country/Region (2021-2026)
Table 47. Global Chicken Newcastle Disease Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Chicken Newcastle Disease Vaccine Sales by Country (2021-2026) & (K Doses)
Table 50. Americas Chicken Newcastle Disease Vaccine Sales Market Share by Country (2021-2026)
Table 51. Americas Chicken Newcastle Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Chicken Newcastle Disease Vaccine Sales by Type (2021-2026) & (K Doses)
Table 53. Americas Chicken Newcastle Disease Vaccine Sales by Application (2021-2026) & (K Doses)
Table 54. APAC Chicken Newcastle Disease Vaccine Sales by Region (2021-2026) & (K Doses)
Table 55. APAC Chicken Newcastle Disease Vaccine Sales Market Share by Region (2021-2026)
Table 56. APAC Chicken Newcastle Disease Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Chicken Newcastle Disease Vaccine Sales by Type (2021-2026) & (K Doses)
Table 58. APAC Chicken Newcastle Disease Vaccine Sales by Application (2021-2026) & (K Doses)
Table 59. Europe Chicken Newcastle Disease Vaccine Sales by Country (2021-2026) & (K Doses)
Table 60. Europe Chicken Newcastle Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Chicken Newcastle Disease Vaccine Sales by Type (2021-2026) & (K Doses)
Table 62. Europe Chicken Newcastle Disease Vaccine Sales by Application (2021-2026) & (K Doses)
Table 63. Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Country (2021-2026) & (K Doses)
Table 64. Middle East & Africa Chicken Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Type (2021-2026) & (K Doses)
Table 66. Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Application (2021-2026) & (K Doses)
Table 67. Key Market Drivers & Growth Opportunities of Chicken Newcastle Disease Vaccine
Table 68. Key Market Challenges & Risks of Chicken Newcastle Disease Vaccine
Table 69. Key Industry Trends of Chicken Newcastle Disease Vaccine
Table 70. Chicken Newcastle Disease Vaccine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Chicken Newcastle Disease Vaccine Distributors List
Table 73. Chicken Newcastle Disease Vaccine Customer List
Table 74. Global Chicken Newcastle Disease Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 75. Global Chicken Newcastle Disease Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Chicken Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 77. Americas Chicken Newcastle Disease Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Chicken Newcastle Disease Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 79. APAC Chicken Newcastle Disease Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Chicken Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 81. Europe Chicken Newcastle Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Chicken Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 83. Middle East & Africa Chicken Newcastle Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Chicken Newcastle Disease Vaccine Sales Forecast by Type (2027-2032) & (K Doses)
Table 85. Global Chicken Newcastle Disease Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Chicken Newcastle Disease Vaccine Sales Forecast by Application (2027-2032) & (K Doses)
Table 87. Global Chicken Newcastle Disease Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Boehringer Ingelheim Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Boehringer Ingelheim Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 90. Boehringer Ingelheim Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Latest Developments
Table 93. CEVA Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. CEVA Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 95. CEVA Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 96. CEVA Main Business
Table 97. CEVA Latest Developments
Table 98. CAHIC Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. CAHIC Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 100. CAHIC Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 101. CAHIC Main Business
Table 102. CAHIC Latest Developments
Table 103. Ringpu Biology Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Ringpu Biology Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 105. Ringpu Biology Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 106. Ringpu Biology Main Business
Table 107. Ringpu Biology Latest Developments
Table 108. Yebio Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Yebio Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 110. Yebio Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 111. Yebio Main Business
Table 112. Yebio Latest Developments
Table 113. Harbin Veterinary Research Institute Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Harbin Veterinary Research Institute Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 115. Harbin Veterinary Research Institute Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 116. Harbin Veterinary Research Institute Main Business
Table 117. Harbin Veterinary Research Institute Latest Developments
Table 118. Merck Animal Health Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Merck Animal Health Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 120. Merck Animal Health Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 121. Merck Animal Health Main Business
Table 122. Merck Animal Health Latest Developments
Table 123. DHN Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. DHN Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 125. DHN Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 126. DHN Main Business
Table 127. DHN Latest Developments
Table 128. Zoetis Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Zoetis Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 130. Zoetis Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 131. Zoetis Main Business
Table 132. Zoetis Latest Developments
Table 133. Elanco Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Elanco Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 135. Elanco Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 136. Elanco Main Business
Table 137. Elanco Latest Developments
Table 138. FATRO Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. FATRO Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 140. FATRO Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 141. FATRO Main Business
Table 142. FATRO Latest Developments
Table 143. CAVAC Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. CAVAC Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 145. CAVAC Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 146. CAVAC Main Business
Table 147. CAVAC Latest Developments
Table 148. Vaksindo Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Vaksindo Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 150. Vaksindo Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 151. Vaksindo Main Business
Table 152. Vaksindo Latest Developments
Table 153. Virbac Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Virbac Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 155. Virbac Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 156. Virbac Main Business
Table 157. Virbac Latest Developments
Table 158. Hester Biosciences Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. Hester Biosciences Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 160. Hester Biosciences Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 161. Hester Biosciences Main Business
Table 162. Hester Biosciences Latest Developments
Table 1. Chicken Newcastle Disease Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Chicken Newcastle Disease Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Live Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Global Chicken Newcastle Disease Vaccine Sales by Type (2021-2026) & (K Doses)
Table 6. Global Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Chicken Newcastle Disease Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Chicken Newcastle Disease Vaccine Sale Price by Type (2021-2026) & (US$/K Doses)
Table 10. Major Players of Spray Method
Table 11. Major Players of Drinking Water
Table 12. Major Players of Injection Method
Table 13. Global Chicken Newcastle Disease Vaccine Sales by Administration (2021-2026) & (K Doses)
Table 14. Global Chicken Newcastle Disease Vaccine Sales Market Share by Administration (2021-2026)
Table 15. Global Chicken Newcastle Disease Vaccine Revenue by Administration (2021-2026) & ($ million)
Table 16. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Administration (2021-2026)
Table 17. Global Chicken Newcastle Disease Vaccine Sale Price by Administration (2021-2026) & (US$/K Doses)
Table 18. Major Players of Large Farms
Table 19. Major Players of Small Farms
Table 20. Major Players of Government Use
Table 21. Global Chicken Newcastle Disease Vaccine Sales by End User (2021-2026) & (K Doses)
Table 22. Global Chicken Newcastle Disease Vaccine Sales Market Share by End User (2021-2026)
Table 23. Global Chicken Newcastle Disease Vaccine Revenue by End User (2021-2026) & ($ million)
Table 24. Global Chicken Newcastle Disease Vaccine Revenue Market Share by End User (2021-2026)
Table 25. Global Chicken Newcastle Disease Vaccine Sale Price by End User (2021-2026) & (US$/K Doses)
Table 26. Global Chicken Newcastle Disease Vaccine Sale by Application (2021-2026) & (K Doses)
Table 27. Global Chicken Newcastle Disease Vaccine Sale Market Share by Application (2021-2026)
Table 28. Global Chicken Newcastle Disease Vaccine Revenue by Application (2021-2026) & ($ million)
Table 29. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Application (2021-2026)
Table 30. Global Chicken Newcastle Disease Vaccine Sale Price by Application (2021-2026) & (US$/K Doses)
Table 31. Global Chicken Newcastle Disease Vaccine Sales by Company (2021-2026) & (K Doses)
Table 32. Global Chicken Newcastle Disease Vaccine Sales Market Share by Company (2021-2026)
Table 33. Global Chicken Newcastle Disease Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Company (2021-2026)
Table 35. Global Chicken Newcastle Disease Vaccine Sale Price by Company (2021-2026) & (US$/K Doses)
Table 36. Key Manufacturers Chicken Newcastle Disease Vaccine Producing Area Distribution and Sales Area
Table 37. Players Chicken Newcastle Disease Vaccine Products Offered
Table 38. Chicken Newcastle Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Chicken Newcastle Disease Vaccine Sales by Geographic Region (2021-2026) & (K Doses)
Table 42. Global Chicken Newcastle Disease Vaccine Sales Market Share Geographic Region (2021-2026)
Table 43. Global Chicken Newcastle Disease Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Chicken Newcastle Disease Vaccine Sales by Country/Region (2021-2026) & (K Doses)
Table 46. Global Chicken Newcastle Disease Vaccine Sales Market Share by Country/Region (2021-2026)
Table 47. Global Chicken Newcastle Disease Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Chicken Newcastle Disease Vaccine Sales by Country (2021-2026) & (K Doses)
Table 50. Americas Chicken Newcastle Disease Vaccine Sales Market Share by Country (2021-2026)
Table 51. Americas Chicken Newcastle Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Chicken Newcastle Disease Vaccine Sales by Type (2021-2026) & (K Doses)
Table 53. Americas Chicken Newcastle Disease Vaccine Sales by Application (2021-2026) & (K Doses)
Table 54. APAC Chicken Newcastle Disease Vaccine Sales by Region (2021-2026) & (K Doses)
Table 55. APAC Chicken Newcastle Disease Vaccine Sales Market Share by Region (2021-2026)
Table 56. APAC Chicken Newcastle Disease Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Chicken Newcastle Disease Vaccine Sales by Type (2021-2026) & (K Doses)
Table 58. APAC Chicken Newcastle Disease Vaccine Sales by Application (2021-2026) & (K Doses)
Table 59. Europe Chicken Newcastle Disease Vaccine Sales by Country (2021-2026) & (K Doses)
Table 60. Europe Chicken Newcastle Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Chicken Newcastle Disease Vaccine Sales by Type (2021-2026) & (K Doses)
Table 62. Europe Chicken Newcastle Disease Vaccine Sales by Application (2021-2026) & (K Doses)
Table 63. Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Country (2021-2026) & (K Doses)
Table 64. Middle East & Africa Chicken Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Type (2021-2026) & (K Doses)
Table 66. Middle East & Africa Chicken Newcastle Disease Vaccine Sales by Application (2021-2026) & (K Doses)
Table 67. Key Market Drivers & Growth Opportunities of Chicken Newcastle Disease Vaccine
Table 68. Key Market Challenges & Risks of Chicken Newcastle Disease Vaccine
Table 69. Key Industry Trends of Chicken Newcastle Disease Vaccine
Table 70. Chicken Newcastle Disease Vaccine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Chicken Newcastle Disease Vaccine Distributors List
Table 73. Chicken Newcastle Disease Vaccine Customer List
Table 74. Global Chicken Newcastle Disease Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 75. Global Chicken Newcastle Disease Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Chicken Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 77. Americas Chicken Newcastle Disease Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Chicken Newcastle Disease Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 79. APAC Chicken Newcastle Disease Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Chicken Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 81. Europe Chicken Newcastle Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Chicken Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 83. Middle East & Africa Chicken Newcastle Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Chicken Newcastle Disease Vaccine Sales Forecast by Type (2027-2032) & (K Doses)
Table 85. Global Chicken Newcastle Disease Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Chicken Newcastle Disease Vaccine Sales Forecast by Application (2027-2032) & (K Doses)
Table 87. Global Chicken Newcastle Disease Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Boehringer Ingelheim Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Boehringer Ingelheim Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 90. Boehringer Ingelheim Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Latest Developments
Table 93. CEVA Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. CEVA Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 95. CEVA Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 96. CEVA Main Business
Table 97. CEVA Latest Developments
Table 98. CAHIC Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. CAHIC Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 100. CAHIC Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 101. CAHIC Main Business
Table 102. CAHIC Latest Developments
Table 103. Ringpu Biology Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Ringpu Biology Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 105. Ringpu Biology Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 106. Ringpu Biology Main Business
Table 107. Ringpu Biology Latest Developments
Table 108. Yebio Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Yebio Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 110. Yebio Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 111. Yebio Main Business
Table 112. Yebio Latest Developments
Table 113. Harbin Veterinary Research Institute Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Harbin Veterinary Research Institute Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 115. Harbin Veterinary Research Institute Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 116. Harbin Veterinary Research Institute Main Business
Table 117. Harbin Veterinary Research Institute Latest Developments
Table 118. Merck Animal Health Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Merck Animal Health Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 120. Merck Animal Health Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 121. Merck Animal Health Main Business
Table 122. Merck Animal Health Latest Developments
Table 123. DHN Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. DHN Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 125. DHN Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 126. DHN Main Business
Table 127. DHN Latest Developments
Table 128. Zoetis Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Zoetis Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 130. Zoetis Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 131. Zoetis Main Business
Table 132. Zoetis Latest Developments
Table 133. Elanco Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Elanco Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 135. Elanco Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 136. Elanco Main Business
Table 137. Elanco Latest Developments
Table 138. FATRO Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. FATRO Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 140. FATRO Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 141. FATRO Main Business
Table 142. FATRO Latest Developments
Table 143. CAVAC Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. CAVAC Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 145. CAVAC Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 146. CAVAC Main Business
Table 147. CAVAC Latest Developments
Table 148. Vaksindo Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Vaksindo Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 150. Vaksindo Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 151. Vaksindo Main Business
Table 152. Vaksindo Latest Developments
Table 153. Virbac Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Virbac Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 155. Virbac Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 156. Virbac Main Business
Table 157. Virbac Latest Developments
Table 158. Hester Biosciences Basic Information, Chicken Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. Hester Biosciences Chicken Newcastle Disease Vaccine Product Portfolios and Specifications
Table 160. Hester Biosciences Chicken Newcastle Disease Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/K Doses) and Gross Margin (2021-2026)
Table 161. Hester Biosciences Main Business
Table 162. Hester Biosciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Chicken Newcastle Disease Vaccine
Figure 2. Chicken Newcastle Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chicken Newcastle Disease Vaccine Sales Growth Rate 2021-2032 (K Doses)
Figure 7. Global Chicken Newcastle Disease Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Chicken Newcastle Disease Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Chicken Newcastle Disease Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Chicken Newcastle Disease Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Live Vaccine
Figure 12. Product Picture of Inactivated Vaccine
Figure 13. Global Chicken Newcastle Disease Vaccine Sales Market Share by Type in 2026
Figure 14. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Spray Method
Figure 16. Product Picture of Drinking Water
Figure 17. Product Picture of Injection Method
Figure 18. Global Chicken Newcastle Disease Vaccine Sales Market Share by Administration in 2026
Figure 19. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Administration (2021-2026)
Figure 20. Product Picture of Large Farms
Figure 21. Product Picture of Small Farms
Figure 22. Product Picture of Government Use
Figure 23. Global Chicken Newcastle Disease Vaccine Sales Market Share by End User in 2026
Figure 24. Global Chicken Newcastle Disease Vaccine Revenue Market Share by End User (2021-2026)
Figure 25. Chicken Newcastle Disease Vaccine Consumed in Chicken
Figure 26. Global Chicken Newcastle Disease Vaccine Market: Chicken (2021-2026) & (K Doses)
Figure 27. Chicken Newcastle Disease Vaccine Consumed in Adult Chicken
Figure 28. Global Chicken Newcastle Disease Vaccine Market: Adult Chicken (2021-2026) & (K Doses)
Figure 29. Global Chicken Newcastle Disease Vaccine Sale Market Share by Application (2025)
Figure 30. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Application in 2025
Figure 31. Chicken Newcastle Disease Vaccine Sales by Company in 2025 (K Doses)
Figure 32. Global Chicken Newcastle Disease Vaccine Sales Market Share by Company in 2025
Figure 33. Chicken Newcastle Disease Vaccine Revenue by Company in 2025 ($ millions)
Figure 34. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Company in 2025
Figure 35. Global Chicken Newcastle Disease Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Chicken Newcastle Disease Vaccine Sales 2021-2026 (K Doses)
Figure 38. Americas Chicken Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 39. APAC Chicken Newcastle Disease Vaccine Sales 2021-2026 (K Doses)
Figure 40. APAC Chicken Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 41. Europe Chicken Newcastle Disease Vaccine Sales 2021-2026 (K Doses)
Figure 42. Europe Chicken Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Chicken Newcastle Disease Vaccine Sales 2021-2026 (K Doses)
Figure 44. Middle East & Africa Chicken Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 45. Americas Chicken Newcastle Disease Vaccine Sales Market Share by Country in 2025
Figure 46. Americas Chicken Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 47. Americas Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 48. Americas Chicken Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 49. United States Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Chicken Newcastle Disease Vaccine Sales Market Share by Region in 2025
Figure 54. APAC Chicken Newcastle Disease Vaccine Revenue Market Share by Region (2021-2026)
Figure 55. APAC Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 56. APAC Chicken Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 57. China Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. India Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Chicken Newcastle Disease Vaccine Sales Market Share by Country in 2025
Figure 65. Europe Chicken Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 66. Europe Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Europe Chicken Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Germany Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. France Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Chicken Newcastle Disease Vaccine Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Chicken Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 76. Egypt Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Chicken Newcastle Disease Vaccine in 2026
Figure 82. Manufacturing Process Analysis of Chicken Newcastle Disease Vaccine
Figure 83. Industry Chain Structure of Chicken Newcastle Disease Vaccine
Figure 84. Channels of Distribution
Figure 85. Global Chicken Newcastle Disease Vaccine Sales Market Forecast by Region (2027-2032)
Figure 86. Global Chicken Newcastle Disease Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Chicken Newcastle Disease Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Chicken Newcastle Disease Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Chicken Newcastle Disease Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Chicken Newcastle Disease Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Chicken Newcastle Disease Vaccine
Figure 2. Chicken Newcastle Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chicken Newcastle Disease Vaccine Sales Growth Rate 2021-2032 (K Doses)
Figure 7. Global Chicken Newcastle Disease Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Chicken Newcastle Disease Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Chicken Newcastle Disease Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Chicken Newcastle Disease Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Live Vaccine
Figure 12. Product Picture of Inactivated Vaccine
Figure 13. Global Chicken Newcastle Disease Vaccine Sales Market Share by Type in 2026
Figure 14. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Spray Method
Figure 16. Product Picture of Drinking Water
Figure 17. Product Picture of Injection Method
Figure 18. Global Chicken Newcastle Disease Vaccine Sales Market Share by Administration in 2026
Figure 19. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Administration (2021-2026)
Figure 20. Product Picture of Large Farms
Figure 21. Product Picture of Small Farms
Figure 22. Product Picture of Government Use
Figure 23. Global Chicken Newcastle Disease Vaccine Sales Market Share by End User in 2026
Figure 24. Global Chicken Newcastle Disease Vaccine Revenue Market Share by End User (2021-2026)
Figure 25. Chicken Newcastle Disease Vaccine Consumed in Chicken
Figure 26. Global Chicken Newcastle Disease Vaccine Market: Chicken (2021-2026) & (K Doses)
Figure 27. Chicken Newcastle Disease Vaccine Consumed in Adult Chicken
Figure 28. Global Chicken Newcastle Disease Vaccine Market: Adult Chicken (2021-2026) & (K Doses)
Figure 29. Global Chicken Newcastle Disease Vaccine Sale Market Share by Application (2025)
Figure 30. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Application in 2025
Figure 31. Chicken Newcastle Disease Vaccine Sales by Company in 2025 (K Doses)
Figure 32. Global Chicken Newcastle Disease Vaccine Sales Market Share by Company in 2025
Figure 33. Chicken Newcastle Disease Vaccine Revenue by Company in 2025 ($ millions)
Figure 34. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Company in 2025
Figure 35. Global Chicken Newcastle Disease Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Chicken Newcastle Disease Vaccine Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Chicken Newcastle Disease Vaccine Sales 2021-2026 (K Doses)
Figure 38. Americas Chicken Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 39. APAC Chicken Newcastle Disease Vaccine Sales 2021-2026 (K Doses)
Figure 40. APAC Chicken Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 41. Europe Chicken Newcastle Disease Vaccine Sales 2021-2026 (K Doses)
Figure 42. Europe Chicken Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Chicken Newcastle Disease Vaccine Sales 2021-2026 (K Doses)
Figure 44. Middle East & Africa Chicken Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 45. Americas Chicken Newcastle Disease Vaccine Sales Market Share by Country in 2025
Figure 46. Americas Chicken Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 47. Americas Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 48. Americas Chicken Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 49. United States Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Chicken Newcastle Disease Vaccine Sales Market Share by Region in 2025
Figure 54. APAC Chicken Newcastle Disease Vaccine Revenue Market Share by Region (2021-2026)
Figure 55. APAC Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 56. APAC Chicken Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 57. China Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. India Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Chicken Newcastle Disease Vaccine Sales Market Share by Country in 2025
Figure 65. Europe Chicken Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 66. Europe Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Europe Chicken Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Germany Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. France Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Chicken Newcastle Disease Vaccine Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Chicken Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Chicken Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 76. Egypt Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Chicken Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Chicken Newcastle Disease Vaccine in 2026
Figure 82. Manufacturing Process Analysis of Chicken Newcastle Disease Vaccine
Figure 83. Industry Chain Structure of Chicken Newcastle Disease Vaccine
Figure 84. Channels of Distribution
Figure 85. Global Chicken Newcastle Disease Vaccine Sales Market Forecast by Region (2027-2032)
Figure 86. Global Chicken Newcastle Disease Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Chicken Newcastle Disease Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Chicken Newcastle Disease Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Chicken Newcastle Disease Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Chicken Newcastle Disease Vaccine Revenue Market Share Forecast by Application (2027-2032)
